IAS/UPSC Coaching Institute  

Article 3: AI-Powered Devices to Spot Signs of Cancer

Why in News: Researchers from IITs showcased affordable AI-powered diagnostic devices for early cancer detection at the AI Impact Summit 2026.


Key Details

  • IIT researchers have developed AI tools for breast cancer, oral cancer, eye disease, and breath-based diagnostics.
  • The devices aim to improve early detection, accuracy, and accessibility, especially in resource-scarce settings.
  • Tools such as MammoX and AI-enabled breath analysers are non-invasive and cost-effective.
  • These innovations support India’s push for AI-driven healthcare transformation.


AI in Healthcare: Emerging Transformational Tool

  • Improving Diagnostic Accuracy: Artificial Intelligence enables pattern recognition in medical data, helping detect diseases earlier than conventional methods. This is crucial as early cancer detection significantly improves survival rates.
  • Reducing Human Error: AI systems assist doctors by flagging abnormalities, thereby reducing oversight in radiology and pathology. Studies indicate that AI-assisted screening can lower diagnostic miss rates.
  • Addressing Healthcare Workforce Gaps: India faces a shortage of radiologists and specialists, particularly in rural areas. AI tools can support primary healthcare workers and reduce the urban-rural healthcare divide.
  • Supporting Digital Health Mission: AI-based diagnostics align with initiatives like the Ayushman Bharat Digital Mission (ABDM), which aims to create an integrated digital health ecosystem.


MammoX: AI-Based Breast Cancer Screening

  • Tackling Missed Diagnoses: Nearly 20% of breast cancer cases are missed in conventional radiology. MammoX analyses mammography scans and highlights suspicious regions for radiologists.
  • Risk Stratification Feature: The platform classifies patients into high-risk and low-risk categories, enabling prioritisation of critical cases and faster clinical decision-making.
  • Integration with Hospital Systems: MammoX retrieves data from PACS (Picture Archiving and Communication System), ensuring seamless workflow integration in hospitals.
  • Collaborative Validation: The tool is being validated in partnership with hospitals such as Max Hospital, Saket, enhancing clinical reliability and real-world applicability.


AI-Enabled Breath Analysers: Non-Invasive Diagnostics

  • Principle of VOC Detection: Human breath contains volatile organic compounds (VOCs) like ammonia, acetone, and formaldehyde, which can indicate disease conditions.
  • Hand-Held and Affordable Design: The device developed at IIT Kharagpur is portable and user-friendly, making it suitable for mass screening and primary health centres.
  • Time-Series Signal Processing: AI algorithms analyse breath signals to estimate gas concentrations, enabling early disease detection without blood tests or imaging.
  • Potential Multi-Disease Application: Beyond cancer, breath analysers can be used for metabolic disorders, lung diseases, and infectious disease screening, expanding their public health value.


Improving Accessibility in Resource-Scarce Settings

  • Bridging Rural Healthcare Gaps: Affordable AI devices can be deployed in district hospitals and PHCs, where advanced diagnostic infrastructure is limited.
  • Cost-Effectiveness: Non-invasive tools reduce dependence on expensive imaging and laboratory tests, lowering out-of-pocket expenditure for patients.
  • Scalability for Mass Screening: Portable AI devices enable population-level screening programmes, particularly important for cancers like breast and oral cancer in India.
  • Supporting Preventive Healthcare: Early detection shifts the system from curative to preventive healthcare, reducing long-term treatment burden.


Challenges and Concerns

  • Data Privacy and Security: AI systems rely on large health datasets, raising concerns regarding patient consent, data protection, and cybersecurity.
  • Algorithmic Bias: AI models trained on limited datasets may produce biased results across populations, necessitating diverse and representative data.
  • Regulatory Approval: Medical AI devices require robust validation and approval from bodies such as CDSCO, which can slow deployment.
  • Doctor–AI Integration: AI should augment, not replace, clinical judgment; proper training and trust-building among healthcare professionals is essential.


Relevance for India’s Health and Innovation Ecosystem

  • Boost to MedTech Innovation: IIT-led innovations strengthen India’s position in AI-driven medical technology and support the Make in India initiative.
  • Alignment with National Health Goals: These tools contribute to reducing the burden of non-communicable diseases (NCDs), which account for over 60% of deaths in India.
  • Global Competitiveness: Affordable AI diagnostics from India can serve Global South markets, enhancing health diplomacy.
  • Interdisciplinary Research Push: Collaboration between engineering institutes and hospitals reflects the growing importance of translational research.


Conclusion

AI-powered diagnostic devices developed by IITs represent a significant step toward accessible, affordable, and accurate healthcare in India. However, their large-scale deployment requires robust clinical validation, regulatory clarity, data protection safeguards, and integration with public health systems. If implemented responsibly, AI can become a cornerstone of India’s preventive and precision healthcare ecosystem.


EXPECTED QUESTION FOR UPSC CSE

Prelims MCQ

Q. AI-enabled breath analysers detect diseases primarily by analysing:
(a) Blood glucose levels
(b) Volatile organic compounds in breath
(c) Body temperature
(d) Oxygen saturation
Answer: (b)